Fleischman Michael Wayne, Budoff Matthew, Zeb Ifran, Li Dong, Foster Temitope
Michael Wayne Fleischman, Temitope Foster, Division of Digestive Diseases, Department of Medicine, Emory University, Atlanta, GA 30324, United States.
World J Gastroenterol. 2014 May 7;20(17):4987-93. doi: 10.3748/wjg.v20.i17.4987.
To compare prevalence rates of non-alcoholic fatty liver disease (NAFLD) between Hispanics of Mexican origin and Hispanics of Dominican and Puerto Rican origin.
We evaluated prevalence rates of NAFLD between the two largest sub-populations of Hispanics in the United States; Hispanics of Mexican origin and Hispanics of Caribbean origin (Dominican and Puerto Rican), in the multi-ethnic study of atherosclerosis (MESA) cohort. MESA is a large, population based, multi-center cohort study comprised of 6814 healthy Caucasian, African-American, Hispanic, and Asian men and women aged 45-84. We utilized the baseline serum, anthropometric and radiographic measurements obtained between 2000 and 2002. NAFLD was measured via computed tomography scan and was defined as liver/spleen attenuation ratio < 1.
There were 788 Hispanic participants included in the study after exclusions. The prevalence of NAFLD was 29% (n = 225). Hispanics of Mexican origin had a significantly higher prevalence of NAFLD (33%), compared to Hispanics of Dominican origin (16%), (P < 0.01) and Hispanics of Puerto Rican origin (18%), (P < 0.01). After controlling for age, sex, BMI, waist circumference, hypertension, serum HDL, triglyceride and CRP level and insulin resistance, Hispanics of Mexican origin remained significantly more likely to have NAFLD than those of Dominican and Puerto Rican origin.
United States Hispanics of Mexican origin have a significantly higher prevalence of NAFLD when compared to United States Hispanics of Dominican or Puerto Rican origin after controlling for known risk factors. Care should be taken when performing risk assessment in Hispanic populations not to make assumptions of homogeneity.
比较墨西哥裔西班牙人与多米尼加裔和波多黎各裔西班牙人非酒精性脂肪性肝病(NAFLD)的患病率。
在动脉粥样硬化多族裔研究(MESA)队列中,我们评估了美国西班牙裔两个最大亚群体(墨西哥裔西班牙人和加勒比裔西班牙人(多米尼加裔和波多黎各裔))中NAFLD的患病率。MESA是一项大型的、基于人群的多中心队列研究,由6814名年龄在45 - 84岁的健康白种人、非裔美国人、西班牙裔和亚裔男性及女性组成。我们利用了2000年至2002年间获得的基线血清、人体测量和影像学测量数据。通过计算机断层扫描测量NAFLD,其定义为肝/脾衰减比<1。
排除后,研究纳入了788名西班牙裔参与者。NAFLD的患病率为29%(n = 225)。与多米尼加裔西班牙人(16%)(P < 0.01)和波多黎各裔西班牙人(18%)(P < 0.01)相比,墨西哥裔西班牙人NAFLD的患病率显著更高(33%)。在控制了年龄、性别、体重指数、腰围、高血压、血清高密度脂蛋白、甘油三酯和CRP水平以及胰岛素抵抗后,墨西哥裔西班牙人患NAFLD的可能性仍显著高于多米尼加裔和波多黎各裔西班牙人。
在控制已知危险因素后,与多米尼加裔或波多黎各裔美国西班牙人相比,墨西哥裔美国西班牙人NAFLD的患病率显著更高。在对西班牙裔人群进行风险评估时应谨慎,不要假设其同质性。